These results suggest that increased levels of BRF2 in cancer cells ensures abundant production of SeCys tRNA and thus of selenoproteins, which in turn confers resistance to oxidative stress and apoptosis (Gouge et al. 2015). This evidence concerns the gene BRF2 and cancer.